GL1X · GenesisL1 explorer

MolNFT v1 · #158790 · protein

Crystal structure of enolase from chlamydia trachomatis

6O4N: “Crystal structure of enolase from chlamydia trachomatis”. X-ray diffraction, 3 ligands (MG, PO4, CL), 9 pockets (best druggability 0.75). MolNFT v1 #158790 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
6O4N
Type
protein
Length
844 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Enolase
EC
4.2.1.11
UniProt
B0BA40
Ligands
MG, PO4, CL
Pockets
9 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BEnolase (EC 4.2.1.11)protein42241% helix, 19% strandB0BA40

Ligands and binding sites

  • MG · Magnesium ion · metal · 5 copies · chains A, B
  • PO4 · Phosphate ion · ion · 2 copies · chains A, B
  • CL · Chloride ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 8 copies · chains A, B
  • MRD · (4R)-2-methylpentane-2,4-diol · additive · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

9 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19450.750.7860MRD
21440.650.8750CL, EDO
3810.400.7819empty
4590.400.8013MRD
5660.380.7914MRD

Interfaces

1 interface between chains.

  • A–B · 1741 Ų buried · 21 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 6O4N · Crystal Structure of Enolase from Chlamydia trachomatis · the same entry in another collection · chain A against A, TM-score 1.00
  • B0BA40 · AlphaFold monomer V2.0 prediction for enolase (B0BA40) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.